Penile Cancer Treatment Options

• Treatment for penile cancer is highly individualized, depending on the cancer’s stage, grade, and the patient’s overall health.
• Surgery — ranging from local excision, laser surgery, or Mohs surgery to partial or total penectomy — is the most common treatment across all stages of penile cancer.
• Radiation therapy for penile cancer and chemotherapy for penile cancer are vital non-surgical options, used alone or in combination with surgery.
• Topical immunotherapy is an option for very early, superficial lesions, and clinical trials can offer access to other investigational treatments, particularly for advanced or recurrent disease.
• The penile cancer treatment prognosis varies significantly, emphasizing the importance of early detection and comprehensive follow-up care.

Overview of Penile Cancer Treatment Options

When diagnosed with penile cancer, patients are presented with a range of penile cancer treatment options, tailored to their specific condition. The primary goal is to remove the cancer completely while limiting the impact on the penis’s normal structure and function whenever it is safe to do so. A multidisciplinary team, often including urologists, oncologists, and radiation oncologists, collaborates to determine the most effective approach. These types of penile cancer treatment encompass surgery, radiation, and chemotherapy; topical immunotherapy is an additional option for early, superficial disease, and clinical trials can offer access to newer approaches, particularly for more advanced or recurrent disease.

Factors Influencing Treatment Choice

Several critical factors guide the selection of appropriate penile cancer treatment. These include the tumor’s size, location, and depth of invasion, as well as whether it has spread to lymph nodes or distant sites. The patient’s overall health, age, and personal preferences also play a significant role in decision-making, ensuring a personalized treatment plan.

Staging and Grade of Penile Cancer

The stage and grade of penile cancer are paramount in determining the optimal course of action. Staging describes the extent of the cancer’s spread, from very early, localized tumors to those that involve nearby lymph nodes or have reached distant organs. The grade refers to how abnormal the cancer cells look under a microscope, indicating how quickly they might grow and spread. Early-stage, low-grade cancers are often treated with less invasive methods, while more advanced or higher-grade disease typically requires more extensive, multi-modal therapy. Understanding what are penile cancer treatments begins with a thorough assessment of these pathological characteristics.

Surgical Penile Cancer Treatment Options

The National Cancer Institute notes that surgery is used to treat penile cancer at every stage, though how extensive the operation needs to be depends on the tumor’s size and depth of invasion. The goal is to remove all cancerous tissue with clear margins while preserving as much healthy tissue as possible. There are several penile cancer surgery options available, ranging from minimally invasive, organ-preserving procedures to more extensive resections.

Local Excision and Mohs Surgery

For very early-stage or superficial penile cancers, less invasive surgical techniques may be employed. Local excision involves removing the tumor along with a small margin of healthy tissue. This approach is often suitable for small, non-invasive lesions. Mohs micrographic surgery is another precise technique where the surgeon removes thin layers of skin containing cancer and examines each layer under a microscope until no cancer cells remain. This method is particularly useful for preserving healthy tissue and is often used for cancers on the glans or foreskin, minimizing cosmetic and functional impact. Laser surgery and cryosurgery, which freezes and destroys abnormal tissue, are additional organ-preserving techniques used for superficial disease.

Penectomy Procedures (Partial/Total)

When the cancer is larger, more invasive, or cannot be adequately removed with local excision, a penectomy may be necessary. A partial penectomy involves removing only the cancerous part of the penis, leaving the remaining portion intact. This procedure is often performed for tumors located on the glans or distal shaft, allowing for preservation of some erectile function and the ability to urinate standing up. For more extensive or invasive cancers, a total penectomy may be required, which involves removing the entire penis. In such cases, a new opening for urination is created in the perineum. Evaluating the groin lymph nodes is also an important part of treatment for many patients: a sentinel lymph node biopsy may be used to check nodes that feel normal, while inguinal lymphadenectomy — surgical removal of the lymph nodes — is generally reserved for nodes that are enlarged or confirmed to contain cancer, since this surgery carries a real risk of side effects such as leg swelling.

Radiation and Chemotherapy for Penile Cancer

Beyond surgery, radiation therapy for penile cancer and chemotherapy for penile cancer represent crucial non-surgical treatment modalities. Radiation may be delivered from outside the body or, less commonly, from a radioactive source placed directly into or near the tumor. These therapies can be used as primary treatments, in combination with surgery, or for palliative care to manage symptoms in advanced stages. The choice between these or their combination depends on the cancer’s characteristics and the patient’s overall health.

External Beam Radiation Therapy

External beam radiation therapy (EBRT) uses high-energy rays to destroy cancer cells. For penile cancer, EBRT can be delivered using specialized techniques that precisely target the tumor while sparing surrounding healthy tissue. It may be used as a primary treatment for smaller tumors, especially in patients who wish to avoid surgery or are not candidates for it. Radiation can also be administered after surgery (adjuvant therapy) to eliminate any remaining cancer cells or before surgery (neoadjuvant therapy) to shrink larger tumors, making them easier to remove. Potential side effects include skin irritation, swelling, and urinary symptoms, which are typically managed with supportive care.

Systemic and Topical Chemotherapy

Chemotherapy for penile cancer involves using drugs to kill cancer cells. It can be administered systemically (intravenously or orally), allowing the drugs to travel throughout the body, or topically (applied directly to the skin). Systemic chemotherapy is typically reserved for advanced penile cancer that has spread to lymph nodes or distant sites, or for cases where other treatments have failed. It can also be given before surgery to shrink tumors (neoadjuvant) or after surgery to kill any remaining cancer cells (adjuvant); cisplatin combined with fluorouracil is among the combinations best supported by the available evidence for this use. Topical chemotherapy, such as fluorouracil cream, is used for very early-stage, superficial lesions, particularly carcinoma in situ, to avoid more invasive procedures. Side effects of systemic chemotherapy can be significant and vary depending on the drugs used, but may include fatigue, nausea, hair loss, and increased risk of infection.

Targeted Therapy and Clinical Trials

Beyond surgery, radiation, and chemotherapy, topical immunotherapy has a narrow, established role in treating early penile cancer, and clinical trials can offer access to other investigational approaches, especially for more advanced or recurrent disease.

Immunotherapy Approaches

Immunotherapy is designed to help a patient’s own immune defenses identify and eliminate cancer cells rather than attacking the tumor directly. For penile cancer, the National Cancer Institute identifies topical imiquimod — an immune response modifier cream — as an immunotherapy option, most often used for very early, superficial lesions confined to the skin. Checkpoint inhibitors and other immunotherapy drugs used in some other cancer types are not an established treatment for penile cancer outside of a clinical trial, so patients interested in these newer approaches should ask their care team about trial eligibility.

Participating in Clinical Trials

For patients with advanced, recurrent, or rare forms of penile cancer, participating in clinical trials can provide access to treatments not yet widely available. Clinical trials are research studies that test new drugs, combinations of therapies, or novel approaches to existing treatments. These trials are rigorously conducted to evaluate the safety and efficacy of new interventions. Patients considering clinical trials should discuss the potential benefits and risks with their healthcare team. They offer hope for improved outcomes and contribute valuable knowledge to the broader understanding of penile cancer treatment options.

Prognosis and Life After Penile Cancer Treatment

The penile cancer treatment prognosis varies greatly among individuals, influenced by factors such as the stage at diagnosis, the aggressiveness of the cancer, and the effectiveness of the chosen treatment. Early detection and prompt intervention significantly improve outcomes. Life after treatment involves managing potential side effects, regular follow-up, and focusing on overall quality of life.

Survival Rates and Recurrence

Survival outlook after penile cancer treatment depends heavily on the stage at diagnosis and whether the cancer has reached the lymph nodes, with earlier detection generally associated with better outcomes; this site’s penile cancer survival rate page covers detailed statistics. Recurrence is a concern, particularly in the first few years after treatment, so the follow-up exams, imaging, and biopsies recommended by the care team are important for catching any recurrence early.

Managing Side Effects and Quality of Life

Living with and beyond penile cancer involves managing both the physical and emotional impact of treatment. Side effects can affect urinary function, sexual health, and emotional well-being, and support such as counseling or support groups can help; this site’s guides on managing side effects and living with penile cancer cover these areas in more depth. The goal of penile cancer treatment extends beyond eradicating the disease to restoring as much normal function and well-being as possible.

Frequently Asked Questions

What is the most common initial treatment for early-stage penile cancer?

For early-stage penile cancer, surgical removal is typically the most common initial treatment. This can range from local excision or Mohs surgery to partial penectomy for slightly larger lesions. The aim is to remove the cancer completely while limiting the impact on normal function as much as safely possible.

How does the stage of penile cancer affect treatment decisions?

The stage of penile cancer is the most critical factor influencing treatment decisions. Early-stage, localized cancers are often managed with less invasive surgeries or radiation. As the cancer progresses to involve regional lymph nodes or distant sites, treatment becomes more aggressive, frequently combining surgery with radiation therapy or chemotherapy. Staging guides the choice of treatment intensity, aiming to match the therapy to the extent of the disease.

Are there non-surgical options for penile cancer?

Yes, several non-surgical options are available for penile cancer. Radiation therapy for penile cancer, particularly external beam radiation, can be a primary treatment for smaller tumors or used alongside surgery. Chemotherapy for penile cancer, both topical for superficial lesions and systemic for advanced disease, is also used. Topical immunotherapy is an option for very early, superficial lesions, and clinical trials can offer access to other non-surgical, investigational approaches, particularly for advanced disease.

Sources

• National Cancer Institute – Penile Cancer Treatment
• National Cancer Institute – Penile Cancer Treatment (PDQ®) – Health Professional Version